Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
550 hedge funds and large institutions have $8.08B invested in Exact Sciences in 2022 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 166 increasing their positions, 167 reducing their positions, and 50 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
160% more first-time investments, than exits
New positions opened: 130 | Existing positions closed: 50
54% more capital invested
Capital invested by funds: $5.26B → $8.08B (+$2.82B)
15% more funds holding
Funds holding: 480 → 550 (+70)
0.44% more ownership
Funds ownership: 91.39% → 91.83% (+0.44%)
1% less repeat investments, than reductions
Existing positions increased: 166 | Existing positions reduced: 167
3% less call options, than puts
Call options by funds: $123M | Put options by funds: $127M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$127M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$47.7M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$45.3M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$40.4M |
| 5 |
BlackRock
New York
|
+$37.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$62.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$51.4M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$47.1M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$47.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$39.9M |
EXAS Hedge Fund Activity: Q4 2022 in Review
550 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2022, worth a combined $8.08B — up 54% from $5.26B a quarter earlier.
Buyers outnumbered sellers: 130 funds opened new EXAS positions and 50 closed out — a net gain of 80 holders — while 166 added to existing stakes and 167 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $127M. The largest seller was ARK Investment Management, cutting an estimated $62.2M.
- 550 institutional investors held Exact Sciences (EXAS) as of Q4 2022, up from 480 in Q3 2022.
- Funds reported $8.08B of Exact Sciences stock for Q4 2022, up 54% quarter-over-quarter.
- 130 funds opened new Exact Sciences positions in Q4 2022 and 50 closed out, a net change of +80 holders.
- The largest Exact Sciences buyer in Q4 2022 was JP Morgan Chase, an estimated $127M added.
- The largest Exact Sciences seller in Q4 2022 was ARK Investment Management, an estimated $62.2M sold.
Based on aggregated 13F filings for Q4 2022.